ZYCEVA 100MG TABLET

About

Zyceva 100mg Tablet is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) utilized in the management of specific advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. The drug exerts its therapeutic effect by competitively binding to the ATP-binding site within the intracellular domain of the EGFR tyrosine kinase. This binding prevents the autophosphorylation of the receptor and subsequent activation of downstream signaling pathways, such as the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR pathways, which are critical for cell growth, survival, and proliferation. In cancers driven by activating EGFR mutations, this inhibition effectively halts the uncontrolled cellular processes that contribute to tumor development and progression. Zyceva's targeted mechanism offers a precision medicine approach, leading to significant clinical benefits, including improved progression-free survival and tumor response rates, particularly in patients with identified EGFR mutations. Its oral formulation enhances patient convenience, though adherence and side effect management are crucial.

Uses

• Treatment of advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
• Second-line treatment for NSCLC after failure of platinum-based chemotherapy.
• Used in combination with gemcitabine for metastatic pancreatic cancer.
• Maintenance therapy for patients with stable disease after initial chemotherapy.

Directions For Use

Take orally once daily, preferably on an empty stomach (at least one hour before or two hours after food). Adhere strictly to the prescribed dosage.

Benefits

• Targeted therapy for specific genetic mutations in cancer.
• Oral formulation provides convenience and ease of administration.
• Can significantly improve progression-free survival in selected patients.
• Offers a treatment option for patients with advanced disease.
• May lead to durable responses in sensitive tumors.
• Generally associated with a more favorable toxicity profile than conventional chemotherapy.

Side Effects

• Skin rash (acne-like, dry skin)
• Diarrhea (can be severe and require management)
• Nausea and occasional vomiting
• Fatigue and asthenia
• Anorexia and weight loss
• Ocular irritation (conjunctivitis, dry eyes)
• Interstitial lung disease (ILD) (rare, potentially fatal)
• Abnormal liver function tests
• Paronychia (nail inflammation)
• Hair thinning
• Stomatitis
• Renal dysfunction (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol intake as it may worsen gastrointestinal side effects and potentially elevate liver enzymes.
• Pregnancy - Contraindicated in pregnancy due to potential for serious fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as the drug may be excreted in breast milk and could cause adverse effects in the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary, and liver function should be regularly monitored.
• Kidney - Generally does not require dose adjustment for renal impairment, but close monitoring is advised in severe cases.
• Lung - Patients should be monitored for new or worsening pulmonary symptoms (e.g., shortness of breath, cough, fever) as ILD is a rare but serious risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.